ProText Mobility, Inc. (TXTM) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Deerfield Beach, FL, United States. The current CEO is Dylon Du Plooy.
TXTM has IPO date of 2003-08-19, 1 full-time employees, listed on the Other OTC, a market capitalization of $13.63M.
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.
